Home » Topics » Regulatory » Patents

Patents
RSS

Wuhan LL Science and Technology Development announces nitric oxid donors

Oct. 6, 2016

Sumitomo Dainippon Pharma develops PDE1 inhibitors

Oct. 6, 2016

The Vanderbilt University reports mGlu2 receptor negative allosteric modulators

Oct. 5, 2016

GlaxoSmithKline presents bromodomain inhibitors

Oct. 5, 2016

Bristol-Myers Squibb describes TNF-alpha antagonists

Oct. 5, 2016

Heptares Therapeutics discloses muscarinic M1 and M4 receptor agonists

Oct. 5, 2016

Merck & Co. patents PDE2A inhibitors

Oct. 5, 2016

Calitor Sciences and Sunshine Lake Pharma present PI3K inhibitors

Oct. 4, 2016

Korea University Research and Business Foundation develops TSLP ligands

Oct. 4, 2016

Eli Lilly describes BACE1 inhibitors

Oct. 4, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...